Xometry raises 2026 revenue growth outlook to at least 37%
Bitget2026/11/03 16:02- Xometry raised its fiscal 2026 revenue growth outlook to at least 37% from 33%-34%, driven by approximately 41% marketplace growth.
- Full-year adjusted EBITDA is forecast at $68 million-$68.5 million, versus $18.5 million in fiscal 2025.
- Fourth-quarter 2026 revenue is projected at $254 million-$256 million, representing 32%-33% year-over-year growth.
- Adjusted EBITDA for the quarter is expected at $22 million-$22.5 million, versus $8.4 million a year earlier.
- Third-quarter 2026 revenue rose 40% to $252 million; adjusted EBITDA reached $21.4 million.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny
CoreWeave will release its third-quarter financial report. Whether it can demonstrate that its rapid revenue growth is sufficient to cover the rising financing costs and construction expenditures will directly determine the direction of market confidence.
